Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04331886 · ClinicalTrials.gov registry record
An Observational Study of Patients With Coronavirus Disease 2019
A clinical trial, sponsored by Target PharmaSolutions.
- Completed
- Registry status
- 199
- Enrollment target
NCT04331886 is a clinical trial that has completed, run by Target PharmaSolutions. The registered enrollment target is 199 participants.
The verdict
NCT04331886 has completed, sponsored by Target PharmaSolutions.
- COMPLETED
- Registry status
- 199 participants
- Enrollment target
Study Summary
This is an observational study of patients with COVID-19 designed to specifically address important clinical questions that remain incompletely answered for coronavirus disease 2019.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 199 participants |
| Start Date | 2020-04-13 |
| Est. Completion | 2022-09-26 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04331886
The ClinicalTrials.gov registry entry for NCT04331886 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 199 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Target PharmaSolutions, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04331886 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04331886 about?
NCT04331886 is a clinical study titled "An Observational Study of Patients With Coronavirus Disease 2019". This is an observational study of patients with COVID-19 designed to specifically address important clinical questions that remain incompletely answered for coronavirus disease 2019.
What is the current status of trial NCT04331886?
This trial is currently completed. The enrollment target is 199 participants. The study started on 2020-04-13. Estimated completion is 2022-09-26.
Who is sponsoring clinical trial NCT04331886?
This trial is sponsored by Target PharmaSolutions, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.